Metabonomics in cancer diagnosis: mass spectrometry-based profiling of urinary nucleosides from breast cancer patients

References

• Bartels H, Bohmer M, Heierli C. Serum creatinine determination without protein precipitation. Clinica Chimica Acta 1975; 37: 193–197
   Google Scholar
• Beger RD. 2005. Metabonomics of Cancer. November 1–4. JeffersonAR, USA: Food and Drug Administration.
   Google Scholar
• Bjoerk GR, Ericson JU, Gustafsson CED, Hagervall TG, Joensson YH, Wikstroem PM. Transfer RNA modification. Annual Review of Biochemistry 1987; 56: 263–287
   PubMedGoogle Scholar
• Bullinger D, Frickenschmidt A, Pelzing M, Zey T, Zurek G, Laufer S, Kammerer B. 2005. Identification of urinary nucleosides by ESI-TOF-MS. LC-GC Europe:16–17.
   Google Scholar
• Cortes C, Vapnik V. Support-vector networks. Machine Learning 1995; 20: 273–297
   Web of Science ®Google Scholar
• Dieterle F, Muller-Hagedorn S, Liebich HM, Gauglitz G. Urinary nucleosides as potential tumor markers evaluated by learning vector quantization. Artificial Intelligence in Medicine 2003; 28: 265–279
   PubMed Web of Science ®Google Scholar
• Duan K, Rajapakse JC. SVM-RFE peak selection for cancer classification with mass spectrometry data. Series on Advances in Bioinformatics and Computational Biology 2005; 1: 191–200
   Google Scholar
• Duda R, Hart P, Stork G. Pattern Classification2nd edition. Wiley Interscience, New York 2001
   Google Scholar
• Dudley E, Lemiere F, Van Dongen W, Langridge JI, El Sharkawi S, Games DE, Esmans EL, Newton RP. Analysis of urinary nucleosides. III. Identification of 5′-deoxycytidine in urine of a patient with head and neck cancer. Rapid Communications in Mass Spectrometry 2003; 17: 1132–1136
   PubMedGoogle Scholar
• Furey TS, Cristianini N, Duffy N, Bednarski DW, Schummer M, Haussler D. Support vector machine classification and validation of cancer tissue samples using microarray expression data. Bioinformatics 2000; 16: 906–914
   PubMed Web of Science ®Google Scholar
• Gamache PH, Meyer DF, Granger MC, Acworth IN. Metabolomic applications of electrochemistry/Mass spectrometry. Journal of the American Society of Mass Spectrometry 2004; 15: 1717–1726
   PubMed Web of Science ®Google Scholar
• Griffin JL. The potential of metabonomics in drug safety and toxicology. Drug Discovery Today: Technologies 2004; 1: 285–293
   PubMedGoogle Scholar
• Guyon I, Elisseeff A. An introduction into variable and feature selection. J Machine Learning Research 2003; 3: 1157–1182
   Google Scholar
• Holloway DT, Kon M, DeLisi C. Integrating genomic data to predict transcription factor binding. Genome Informatics 2005; 16: 83–94
   PubMedGoogle Scholar
• Honda K, Hayashida Y, Umaki T, Okusaka T, Kosuge T, Kikuchi S, Endo M, Tsuchida A, Aoki T, Itoi T, Moriyasu F, Hirohashi S, Yamada T. Possible detection of pancreatic cancer by plasma protein profiling. Cancer Research 2005; 65: 10613–10622
   PubMedGoogle Scholar
• Itoh K, Aida S, Ishiwata S, Sasaki S, Ishida N, Mizugaki M. Urinary excretion patterns of modified nucleosides, pseudouridine and 1-methyladenosine, in healthy individuals. Clinica Chimica Acta 1993; 217: 221–223
   PubMed Web of Science ®Google Scholar
• Kammerer B, Frickenschmidt A, Gleiter CH, Laufer S, Liebich H. MALDI-TOF MS analysis of urinary nucleosides. Journal of the American Society of Mass Spectrometry 2005a; 16: 940–947
   PubMedGoogle Scholar
• Kammerer B, Frickenschmidt A, Muller CE, Laufer S, Gleiter CH, Liebich H. Mass spectrometric identification of modified urinary nucleosides used as potential biomedical markers by LC-ITMS coupling. Anals of Bioanalytical Chemistry 2005b; 382: 1017–1026
   PubMedGoogle Scholar
• Kim H, Page GP, Barnes S. Proteomics and mass spectrometry in nutrition research. Nutrition 2004; 20: 155–165
   PubMedGoogle Scholar
• Kleno TG, Kiehr B, Baunsgaard D, Sidelmann UG. Combination of ‘omics’ data to investigate the mechanism(s) of hydrazine-induced hepatotoxicity in rats and to identify potential biomarkers. Biomarkers 2004; 9: 116–138
   PubMed Web of Science ®Google Scholar
• Lenz EM, Bright J, Knight R, Westwood FR, Davies D, Major H, Wilson ID. Metabonomics with 1H-NMR spectroscopy and liquid chromatography-mass spectrometry applied to the investigation of metabolic changes caused by gentamicin-induced nephrotoxicity in the rat. Biomarkers 2005; 10: 173–187
   PubMed Web of Science ®Google Scholar
• Lepp Z, Kinoshita T, Chuman H. Screening for new antidepressant leads of multiple activities by support vector machines. Journal of Chemical Information & Modeling 2006; 46: 158–167
   PubMed Web of Science ®Google Scholar
• Liebich HM, Di SC, Wixforth A, Schmid HR. Quantitation of urinary nucleosides by high-performance liquid chromatography. Jouranl of Chromatography A 1997; 763: 193–197
   PubMed Web of Science ®Google Scholar
• Liebich HM, Muller-Hagedorn S, Bacher M, Scheel-Walter H-G, Lu X, Frickenschmidt A, Kammerer B, Kim K-R, Gerard H. Age-dependence of urinary normal and modified nucleosides in childhood as determined by reversed-phase high-performance liquid chromatography. Journal of Chromatography B Analytical Technologies in the Biomedical & Life Sciences 2005; 814: 275–283
   PubMed Web of Science ®Google Scholar
• Lindon JC, Holmes E, Bollard ME, Stanley EG, Nicholson JK. Metabonomics technologies and their applications in physiological monitoring, drug safety assessment and disease diagnosis. Biomarkers 2004; 9: 1–31
   PubMed Web of Science ®Google Scholar
• Liu Y. Serum proteomic pattern analysis for early cancer detection. Technology in Cancer Research & Treatment 2006; 5: 61–66
   PubMedGoogle Scholar
• Luntz A, Brailovsky V. 1969. On estimation of characters obtained in statistical procedure of recognition. Technicheskaya Kibernetica 3.
   Google Scholar
• Plumb RS, Stumpf CL, Gorenstein MV, Castro-Perez JM, Dear GJ, Anthony M, Sweatman BC, Connor SC, Haselden JN. Metabonomics: the use of electrospray mass spectrometry coupled to reversed-phase liquid chromatography shows potential for the screening of rat urine in drug development. Rapid Communications in Mass Spectrometry 2002; 16: 1991–1996
   PubMed Web of Science ®Google Scholar
• Plumb RS, Stumpf CL, Granger JH, Castro-perez J, Haselden JN, Dear GJ. Use of liquid chromatography/time-of-flight mass spectrometry and multivariate statistical analysis shows promise for the detection of drug metabolites in biological fluids. Rapid Communications in Mass Spectrometry 2003; 17: 2632–2638
   PubMed Web of Science ®Google Scholar
• Prankel BH, Clemens PC, Burmester JG. Urinary excretion of nucleosides varies with age and protein metabolism. Clinica Chimica Acta 1995; 234: 181–183
   PubMedGoogle Scholar
• Rajapakse JC, Duan K, Yeo WK. Proteomic cancer classification with mass spectrometry data. American Journal of Pharmacogenomics 2005; 5: 281–292
   PubMedGoogle Scholar
• Roessner U, Willmitzer L, Fernie AR. Metabolic profiling and biochemical phenotyping of plant systems. Plant Cell Reports 2002; 21: 189–196
   Web of Science ®Google Scholar
• Saeh JC, Lyne PD, Takasaki BK, Cosgrove DA. Lead hopping using SVM and 3D pharmacophore fingerprints. Journal of Chemical Information & Modeling 2005; 45: 1122–1133
   PubMed Web of Science ®Google Scholar
• Sander G, Hulsemann J, Topp H, Heller-Schoch G, Schoch G. Protein and RNA turnover in preterm infants and adults: a comparison based on urinary excretion of 3-methylhistidine and of modified one-way RNA catabolites. Annals of Nutrition & Metabolism 1986; 30: 137–142
   PubMedGoogle Scholar
• Sasco AJ, Rey F, Reynaud C, Bobin JY, Clavel M, Niveleau A. Breast cancer prognostic significance of some modified urinary nucleosides. Cancer Letters 1996; 108: 157–162
   PubMedGoogle Scholar
• Schölkopf B, Smola A. Learning with Kernels. MIT Press, Cambridge 2002
   Google Scholar
• Tormey DC, Waalkes TP, Gehrke CW. Biological markers in breast carcinoma – clinical correlations with pseudouridine, N2,N2-dimethylguanosine, and 1-methylinosine. Journal of Surgical Oncology 1980; 14: 267–273
   PubMedGoogle Scholar
• Wang C, Kong H, Guan Y, Yang J, Gu J, Yang S, Xu G. Plasma phospholipid metabolic profiling and biomarkers of type 2 diabetes mellitus based on high-performance liquid chromatography/electrospray mass spectrometry and multivariate statistical analysis. Anals of Chemistry 2005; 77: 4108–4116
   PubMed Web of Science ®Google Scholar
• Wilson ID, Plumb R, Granger J, Major H, Williams R, Lenz EM. HPLC-MS-based methods for the study of metabonomics. Journal of Chromatography B Analytical Technologies in the Biomedical & Life Sciences 2005; 817: 67–76
   PubMed Web of Science ®Google Scholar
• Xu G, Schmid HR, Lu X, Liebich HM, Lu P. Excretion pattern investigation of urinary normal and modified nucleosides of breast cancer patients by RP-HPLC and factor analysis method. Biomedical Chromatography 2000; 14: 459–463
   PubMedGoogle Scholar
• Yang J, Xu G, Zheng Y, Kong H, Pang T, Lv S, Yang Q. Diagnosis of liver cancer using HPLC-based metabonomics avoiding false-positive result from hepatitis and hepatocirrhosis diseases. Journal of Chromatography B Analytical Technologies in the Biomedical & Life Sciences 2004; 813: 59–65
   PubMed Web of Science ®Google Scholar
• Yang J, Xu G, Zheng Y, Kong H, Wang C, Zhao X, Pang T. Strategy for metabonomics research based on high-performance liquid chromatography and liquid chromatography coupled with tandem mass spectrometry. Journal of Chromatography A 2005; 1084: 214–221
   PubMed Web of Science ®Google Scholar